Cynthia Campbell to Buprenorphine
This is a "connection" page, showing publications Cynthia Campbell has written about Buprenorphine.
Connection Strength
2.739
-
Patient Engagement in a Multimodal Digital Phenotyping Study of Opioid Use Disorder. J Med Internet Res. 2023 06 13; 25:e45556.
Score: 0.794
-
PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment. Addict Sci Clin Pract. 2021 01 31; 16(1):9.
Score: 0.674
-
Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System. J Psychoactive Drugs. 2017 Apr-Jun; 49(2):160-168.
Score: 0.519
-
Risk of self-harm and overdose after starting buprenorphine for opioid use disorder. Gen Hosp Psychiatry. 2025 Sep-Oct; 96:90-96.
Score: 0.229
-
Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV. J Gen Intern Med. 2021 04; 36(4):930-937.
Score: 0.169
-
Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems. J Subst Abuse Treat. 2020 03; 112S:41-48.
Score: 0.158
-
The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose. Drug Alcohol Depend. 2020 04 01; 209:107923.
Score: 0.158
-
Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug Alcohol Depend. 2020 02 01; 207:107732.
Score: 0.039